keyboard_arrow_up

Mexico Pharmaceuticals and Healthcare Market Report Q2 2015

Increased trade activity will promote growth in Mexico’s pharmaceutical and healthcare markets in 2015. In particular, generic medicine will continue to grow over the forecast period, accounting for a larger percentage of total pharmaceutical spending. Indeed, the country will continue to see positive changes as government regulations improve industry appeal to foreign drug makers.

Headline Expenditure Projections:

·  Pharmaceuticals: MXN185bn (USD14bn) in 2014 to MXN192bn (USD15bn) in 2015; +7.2% in local currency terms and +5.8% in US dollar terms. Forecast increased from Q115 due to revised historical data.

·  Healthcare: MXN1,124bn (USD85bn) in 2014 to MXN1,1214bn (USD91bn) in 2015; +8.0% in local currency terms and +6.6% in US dollar terms. Forecast increased from Q115 due to revised historical data.

Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=287707 .

Table of Contents

Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2011-2019) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019) 20
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 25
OTC Medicine Market Forecast 25
Table: Over-The-Counter (Otc) Medicine Market, Historical Data And Forecasts (Mexico 2011-2019) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2013-2019) 30
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Mexico 2013-2019) 30
Key Risks To BMI's Forecast Scenario 30
Macroeconomic Forecasts 32
Economic Analysis 32
Table: Economic Activity (Mexico 2009-2018) 37
Industry Risk Reward Ratings 38
Americas Risk/Reward Index 38
Mexico Risk/Reward Index 43
Rewards 43
Risks 43
Market Overview 45
Industry Trends And Developments 46
Epidemiology 46
Table: Burden Of Non-Communicable Diseases In Mexico (2014-2019) 48
Healthcare Sector 48
Table: Mexico's Healthcare Resources 49
Table: Mexico's Healthcare Activity 49
Table: Mexico's Healthcare Personnel 50
Table: Selected Countries' Medical Tourism Prices In 2011 (USD) 54
Table: List Of Hospitals In Mexico With Joint Commission International (JCI) Accreditation 54
Research & Development 55
Clinical Trials 57
Table: Clinical Trial Regulation In Mexico 58
Regulatory Development 60
Regulatory Environment 60
Biologics And Biosimilars Guidelines 63
Intellectual Property Issues 67
Intellectual Property Challenges 68
Table: Mexican Marketing Applications In Alleged Violation Of Patent Rights 70
Pricing & Reimbursement 71
Reimbursement Issues 76
Competitive Landscape 79
Research-Based Industry 79
Table: Top 10 Pharmaceutical Companies In Mexico By Sales 79
Pharmaceutical Distribution 81
Pharmaceutical Retail Sector 83
Table: IMSS Financial Indicators, 2000-11 (MXNmn) 84
Company Profile 85
Bayer 85
Boehringer Ingelheim 87
Bristol-Myers Squibb 90
Eli Lilly 93
Genomma Labs 96
GlaxoSmithKline (GSK) 102
Merck KGaA 105
Novartis 108
Pfizer 111
Roche 114
Sanofi 118
Demographic Forecast 121
Demographic Outlook 121
Table: Population Headline Indicators (Mexico 1990-2025) 122
Table: Key Population Ratios (Mexico 1990-2025) 122
Table: Urban/Rural Population & Life Expectancy (Mexico 1990-2025) 123
Table: Population By Age Group (Mexico 1990-2025) 123
Table: Population By Age Group % (Mexico 1990-2025) 124
Glossary 126
Methodology 128
Pharmaceutical Expenditure Forecast Model 128
Healthcare Expenditure Forecast Model 128
Notes On Methodology 129
Risk/Reward Index Methodology 130
Index Overview 131
Table: Pharmaceutical Risk/Reward Index Indicators 131
Indicator Weightings 132

List of Tables

Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2011-2019)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019)
Table: Over-The-Counter (Otc) Medicine Market, Historical Data And Forecasts (Mexico 2011-2019)
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Mexico 2013-2019)
Table: Economic Activity (Mexico 2009-2018)
Table: Burden Of Non-Communicable Diseases In Mexico (2014-2019)
Table: Mexico's Healthcare Resources
Table: Mexico's Healthcare Activity
Table: Mexico's Healthcare Personnel
Table: Selected Countries' Medical Tourism Prices In 2011 (USD)
Table: List Of Hospitals In Mexico With Joint Commission International (JCI) Accreditation
Table: Clinical Trial Regulation In Mexico
Table: Mexican Marketing Applications In Alleged Violation Of Patent Rights
Table: Top 10 Pharmaceutical Companies In Mexico By Sales
Table: IMSS Financial Indicators, 2000-11 (MXNmn)
Table: Population Headline Indicators (Mexico 1990-2025)
Table: Key Population Ratios (Mexico 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Mexico 1990-2025)
Table: Population By Age Group (Mexico 1990-2025)
Table: Population By Age Group % (Mexico 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators

Complete Report is Available @ http://www.rnrmarketresearch.com/mexico-pharmaceuticals-and-healthcare-report-q2-2015-market-report.html .